Neurochemical Research

, Volume 19, Issue 1, pp 105–110 | Cite as

Serine protease inhibitors block N-terminal arginylation of proteins by inhibiting the arginylation of tRNA in rat brains

  • Mujun Yu
  • Goutam Chakraborty
  • Michael Grabow
  • Nicholas A. Ingoglia
Original Articles


The tRNA mediated, posttranslational, N-terminal arginylation of proteins occurs in all eukaryotic cells. In nervous tissue, these reactions can be inhibited by endogenous molecules with a molecular weight of between one thousand and five thousand. In the present experiments, exogenous serine protease inhibitors (10−5M or less) but not other types of protease inhibitors, were found to be able to block the arginylation of protein in extracts of rat brain homogenates. Inhibition was not by the usual mode of action of protease inhibitors, but by interfering (non-competitively) with the charging of tRNA. Since arginylated proteins are rapidly ubiquitinated and degraded by cytosolic proteases, serine protease inhibitors may act to stabilize proteins by a dual mechanism of inhibiting arginylation as well as inhibiting serine proteases.

Key Words

Serine protease inhibitors posttranslational modification arginylation tRNA 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kaji, H., Novelli, G. D., and Kaji, A. 1963. A soluble amino acid incorporating system from rat liver. Biochem. Biophys. Acta. 76:474–479.Google Scholar
  2. 2.
    Soffer, R. L., and Horinishi, H. 1969. General characteristics of the arginine-transfer reaction in rabbit liver cytoplasm. J. Mol. Biol. 43:163–169.Google Scholar
  3. 3.
    Barra, H. S., Rodriguez, J. A., Arce, C. A. and Caputto, R. 1973. A soluble preparation from rat brain that incorporates into its own proteins (14C) arginine by an RNase-sensitive system and (14C) tyrosine by an RNase-insensitive system. J. Neurochem. 20:97–105.Google Scholar
  4. 4.
    Ingoglia, N. A., Giuditta, A., Zanakis, M. F., Babigian, A., Tasaki, I., Chakraborty, G., and Sturman, J. 1983. Incorporation of3H-amino acids into proteins in a partially purified fraction of axoplasm: Evidence for transfer RNA mediated, posttranslational protein modification in squid giant axons. J. Neurosci. 3(12):2463–2473.Google Scholar
  5. 5.
    Balzi, E., Choder, M., Chen, W., Varshavsky, A., and Goffeau, A. 1990. Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae. J Biol. Chem. 265:7464–7471.Google Scholar
  6. 6.
    Ferber S., and Ciechanover, A., 1987. Role of arginine tRNA in protein degradation by the ubiquitin pathway. Nature (London) 326:808–811.Google Scholar
  7. 7.
    Elias, S., and Ciechanover A. 1990. Post-translational addition of an arginine moiety to acidic NH2 termini of proteins is required for their recognition by ubiquitin-protein ligase. J. Biol. Chem. 265:15511–15517.Google Scholar
  8. 8.
    Xu, N-S., Chakraborty, G., Hassankhani, A., and Ingoglia, N. 1993. N-terminal arginylation of proteins in explants of injured sciatic nerves and embryonic brains of rats. In press, Neurochem. Res.Google Scholar
  9. 9.
    Chakraborty, G. and Ingoglia, N. A. 1993. N-terminal arginylation and ubiquitin mediated proteolysis in nerve regeneration. Brain Res Bulletin 30:439–445.Google Scholar
  10. 10.
    Hershko, A., and Ciechanover, A. 1992. The ubiquitin system for protein degradation. Ann Rev of Biochem. 61:761–807.Google Scholar
  11. 11.
    Chakraborty, G., Sturman, J. A., and Ingoglia, N. A. 1990. Regulation of the posttranslational conjugation of arginine and lysine to rat brain proteins. Neurosci. 37:215–221.Google Scholar
  12. 12.
    Zanakis, M. F., Chakraborty, G., Sturman, J. A., and Ingoglia, N. A. 1984. Posttranslational protein modification by amino acid addition in intact and regenerating axons of the rat sciatic nerve. J. Neurochem. 43:1286–1294.Google Scholar
  13. 13.
    Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochem. 72:248–254.Google Scholar
  14. 14.
    Ingoglia, N. A., Chakraborty, G., Yu, M., Luo, D., and Sturman, J.A. 1991. Amino acid modified proteins from aggregates in regenerating sciatic nerves of rats. J. Molec. Neurosci. 2:185–192.Google Scholar
  15. 15.
    Sivaram, P., and Deutscher, M. P. 1990. Existence of two forms of rat liver arginyl-tRNA synthetase suggests channeling of aminoacyl-tRNA for protein synthesis. Proc. Natl. Acad. Sci. USA 87:3665–3669.Google Scholar
  16. 16.
    Waxman, L., Smith, D. E., Arcuri, K. E., and Vlasuk, G. P. 1990. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science, 248:593–596.Google Scholar
  17. 17.
    Weitman, D., and Etlinger, J. D. 1992. A monoclonal antibody that distinguishes latent and active forms of the proteosome (multicatalytic proteinase complex). J. Biol. Chem 267 No. 10:6977–6982.Google Scholar
  18. 18.
    Ozaki, M., Fujinami K., Amemiya, Y., Sato, T., Ogura, N., Nakagawa, H. 1992. Purification and initial characterization of the proteosome from the higher plant Spinacia oleracea. J. Biol. Chem. 267(30):21678–21684.Google Scholar
  19. 19.
    Seufert, W., and Jentsch, S. 1992. In vivo function of the proteosome in the ubiquitin pathway. EMBO J. 11 No. 8:3077–3080.Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Mujun Yu
    • 1
    • 2
  • Goutam Chakraborty
  • Michael Grabow
  • Nicholas A. Ingoglia
    • 1
    • 2
  1. 1.Department of PhysiologyNew Jersey Medical SchoolNewark
  2. 2.Department of NeuroscienceNew Jersey Medical SchoolNewark

Personalised recommendations